In 1980 patients with burns greater than 10% of total body surface area (TBSA) received a mean of 8 units of blood (range, 0-42 units) during hospitalization in our burn center. Concern about the risks of blood transfusion caused us to reassess our transfusion practices and to question the need to maintain hematocrits above 30%. We compared the quantity of blood given to burn patients at Harborview Medical Center in 1980 with that given in 1990. Available records were reviewed from all patients with greater than 10% TBSA burns who required at least one operation (1980; n = 41; 1990: n = 38). There were no differences between groups for patients' ages, timing of first excision, or length of hospital stay. There were no differences in extent of burn excision per operation, but surgical times were significantly shorter in 1990 than in 1980. In 1980, 1.2 +/- 1.2 mL of blood was transfused per square centimeter surface area excised, compared with 0.23 +/- 0.49 mL in 1990 (p < 0.0001). In 1980, 133 +/- 153 mL blood was transfused per patient per percent burn during the acute hospitalization, compared with 20 +/- 34 mL in 1990 (p < 0.0001). There have been no instances of myocardial infarction or congestive heart failure related to the maintenance of lower hematocrits. We now permit hematocrits to fall to 15%-20% in healthy patients who need limited operations. In healthy patients with more extensive burns we accept hematocrits of 25%, and only critically ill patients and those with pre-existing cardiovascular disease are transfused to hematocrits of 30% or higher.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00005373-199408000-00012 | DOI Listing |
Res Pract Thromb Haemost
January 2025
Oxford Haemophilia and Thrombosis Centre, Department of Haematology, Oxford University Hospitals National Health Service Foundation Trust, Nuffield Orthopaedic Centre, Oxford, UK.
A state of the art lecture titled "Transfusion therapy in trauma-what to give? Empiric vs guided" was presented at the International Society on Thrombosis and Haemostasis Congress in 2024. Uncontrolled bleeding is the commonest preventable cause of death after traumatic injury. Hemostatic resuscitation is the foundation of contemporary transfusion practice for traumatic bleeding and has 2 main aims: to immediately support the circulating blood volume and to treat/prevent the associated trauma-induced coagulopathy.
View Article and Find Full Text PDFJ Orthop Surg Res
January 2025
Central Coast Local Health District, Gosford, NSW, 2295, Australia.
Background: The use of intravenous tranexamic acid (TXA), an antifibrinolytic agent, has been shown to effectively reduce total blood loss and transfusion rates in total knee arthroplasty (TKA). The aim of this paper is to evaluate the implementation lag and clinical uptake of the use of TXA for primary TKA after publication of two landmark studies. Additionally, it assessed the efficacy of TXA use in TKA in reducing post-operative blood transfusions and hospital length of stay (LOS).
View Article and Find Full Text PDFNature
January 2025
German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany.
Cardiomyocytes can be implanted to remuscularize the failing heart. Challenges include sufficient cardiomyocyte retention for a sustainable therapeutic impact without intolerable side effects, such as arrhythmia and tumour growth. We investigated the hypothesis that epicardial engineered heart muscle (EHM) allografts from induced pluripotent stem cell-derived cardiomyocytes and stromal cells structurally and functionally remuscularize the chronically failing heart without limiting side effects in rhesus macaques.
View Article and Find Full Text PDFCrit Care Med
January 2025
Department of Surgery, Neurology and Neurosurgery Unit, Federal University of Góias, Góias, Brazil.
Objectives: Balancing oxygen requirements, neurologic outcomes, and systemic complications from transfusions in traumatic brain injury (TBI) patients is challenging. This review compares liberal and restrictive transfusion strategies in TBI patients.
Data Sources: Electronic databases were searched from inception to October 2024.
Niger Med J
January 2025
Department of Surgery, Rivers State University Teaching Hospital, Port Harcourt, Nigeria.
Background: Blood transfusion holds a significant place in the practice of surgery, including orthopaedic surgeries. The aim of this study was to evaluate the intraoperative use of blood and blood products among orthopaedic patients operated at the Rivers State University Teaching Hospital from January 2021 to December 2021, focusing on the demographics of patients, number and type of surgeries needing a blood transfusion, and the number of blood transfusions.
Methodology: A retrospective observational study was carried out at the operating theatre of a referral tertiary hospital using a designed proforma to extract data from the registers of operated orthopaedic patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!